ResMed Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $2.07B (year ended Jun 30, 2017) to $5.65B (year ended Jun 30, 2026), a compound annual growth rate of 11.8%. The fastest growth was +18.0% in the year ended Jun 30, 2023; the weakest year was +8.1% (year ended Jun 30, 2021).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Jun 30, 2026 | $5.65B | +9.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 13, 2026 |
| Jun 30, 2025 | $5.15B | +9.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 13, 2026 |
| Jun 30, 2024 | $4.69B | +10.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 13, 2026 |
| Jun 30, 2023 | $4.22B | +18.0% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 8, 2025 |
| Jun 30, 2022 | $3.58B | +11.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 9, 2024 |
| Jun 30, 2021 | $3.20B | +8.1% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Aug 11, 2023 |
| Jun 30, 2020 | $2.96B | +13.4% | Revenues | 10-K filed Aug 13, 2020 |
| Jun 30, 2019 | $2.61B | +11.4% | Revenues | 10-K filed Aug 13, 2020 |
| Jun 30, 2018 | $2.34B | +13.2% | Revenues | 10-K filed Aug 13, 2020 |
| Jun 30, 2017 | $2.07B | +12.4% | Revenues | 10-K filed Aug 8, 2019 |
ResMed Inc. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $1.41B | +5.9% | 10-Q filed Oct 30, 2026 |
| 3 months ended Mar 31, 2026 | $1.43B | +10.8% | 10-Q filed May 1, 2026 |
| 3 months ended Dec 31, 2025 | $1.42B | +11.0% | 10-Q filed Jan 30, 2026 |
| 3 months ended Sep 30, 2025 | $1.34B | +9.1% | 10-Q filed Oct 30, 2026 |
| 3 months ended Mar 31, 2025 | $1.29B | +7.9% | 10-Q filed May 1, 2026 |
| 3 months ended Dec 31, 2024 | $1.28B | +10.3% | 10-Q filed Jan 30, 2026 |
| 3 months ended Sep 30, 2024 | $1.22B | +11.1% | 10-Q filed Oct 31, 2025 |
| 3 months ended Mar 31, 2024 | $1.20B | +7.2% | 10-Q filed Apr 24, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 943819 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.